Cargando…
Are abnormal coagulation studies upon hospital admission in gravidas with COVID-19 associated with adverse outcomes?
Autores principales: | Seasely, Angela R., Gaonkar, Mokshad, Battarbee, Ashley N., Casey, Brian M., Sinkey, Rachel G., Dionne-Odom, Jodie, Szychowski, Jeff M., Tita, Alan T., Subramaniam, Akila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696657/ http://dx.doi.org/10.1016/j.ajog.2021.11.1176 |
Ejemplares similares
-
Hypertensive disorders of pregnancy in pregnant patients following infection with COVID-19
por: Orfanakos, Vasiliki B., et al.
Publicado: (2023) -
Association of social vulnerability index on COVID-19 infection severity during pregnancy
por: Seasely, Angela R., et al.
Publicado: (2023) -
1147 Laboratory evidence of COVID-19 infection in gravidas in the first 6 months of the pandemic
por: Sutton, Desmond, et al.
Publicado: (2021) -
Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19
por: Sinkey, Rachel G., et al.
Publicado: (2020) -
High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin
por: Dionne-Odom, Jodie, et al.
Publicado: (2020)